Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
The Long Run with Luke Timmerman
00:00
Introduction
Exploring VOR Bio's mission to delete CD33 antigen from stem cells using CRISPR gene editing for the treatment of acute myeloid leukemia, along with their development of a CD33-directed CAR-T cell therapy. Guest Robert Ang shares his journey as an immigrant physician turned entrepreneur in biotech.
Transcript
Play full episode
